Orica Ltd
ASX:ORI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orica Ltd
ASX:ORI
|
AU |
|
N
|
Novo Nordisk A/S
F:NOVC
|
DK |
|
P
|
Psybio Therapeutics Corp
XTSX:PSYB
|
CA |
Wall Street
Price Targets
ORI Price Targets Summary
Orica Ltd
According to Wall Street analysts, the average 1-year price target for
ORI
is 26.56 AUD
with a low forecast of 24.28 AUD and a high forecast of 31.5 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ORI's stock price target?
Price Target
26.56
AUD
According to Wall Street analysts, the average 1-year price target for
ORI
is 26.56 AUD
with a low forecast of 24.28 AUD and a high forecast of 31.5 AUD.
What is Orica Ltd's Revenue forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Orica Ltd's revenue is
2%.
The projected
CAGR
for the next 3 years is
3%.
What is Orica Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Orica Ltd's operating income is
0%.
The projected
CAGR
for the next 3 years is
9%.
What is Orica Ltd's Net Income forecast?
Projected CAGR
64%
For the last 14 years the
compound annual growth rate for
Orica Ltd's net income is
-9%.
The projected
CAGR
for the next 3 years is
64%.
